Thyrotroph Thyroid Hormone Sensitivity Index

From WikiMD's WELLNESSPEDIA

Index used to assess thyroid function

The Thyrotroph Thyroid Hormone Sensitivity Index (TTSI) is a calculated parameter used in the evaluation of thyroid function. It provides insight into the sensitivity of the pituitary gland to circulating thyroid hormones, particularly thyroxine (T4) and triiodothyronine (T3). This index is particularly useful in distinguishing between different types of thyroid disorders and assessing the adequacy of thyroid hormone replacement therapy.

Calculation[edit]

The TTSI is calculated using the following formula:

TTSI = (100 × TSH) / (FT4)

where TSH is the thyroid-stimulating hormone level and FT4 is the free thyroxine level. Both TSH and FT4 are measured in standard laboratory units.

Physiological Basis[edit]

The TTSI reflects the feedback mechanism between the pituitary gland and the thyroid gland. In a normal physiological state, the pituitary gland secretes TSH in response to low levels of circulating thyroid hormones. The thyroid gland, in turn, produces T4 and T3, which exert negative feedback on the pituitary to regulate TSH secretion.

Clinical Significance[edit]

The TTSI is particularly useful in the following clinical scenarios:

  • Differentiating Euthyroid from Subclinical Hypothyroidism: In patients with normal TSH but low FT4, a high TTSI may indicate subclinical hypothyroidism.
  • Assessing Thyroid Hormone Resistance: A high TTSI in the presence of normal or elevated thyroid hormone levels may suggest resistance to thyroid hormones at the pituitary level.
  • Monitoring Thyroid Hormone Replacement Therapy: The TTSI can help in adjusting the dose of thyroid hormone replacement in patients with hypothyroidism to ensure adequate suppression of TSH.

Limitations[edit]

While the TTSI is a valuable tool, it should not be used in isolation. It is important to consider the clinical context and other laboratory findings when interpreting the TTSI. Factors such as non-thyroidal illness, medications, and laboratory variability can affect the TTSI.

Related Pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.